NEUTRISCI PROVIDES UPDATE ON PATENT PENDING TECHNOLOGY
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (“NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer [...]
INVESTOR RELATIONS
*15 min delay on quotes.
For all Investor Inquiries: investors@neutrisci.com
CORPORATE PROFILE
NeutriSci International Inc. (TSXV: NU) develops, markets, and distributes clinically-proven nutraceutical products in Canada. Its products include Neuenergy®, an energy chewable tablet designed to deliver enhanced focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a vast distribution network of retail and online channels. NeutriSci International Inc. is headquartered in Calgary, Canada with employees nationwide in Vancouver, Toronto, and Montreal.
NEVER MISS ANOTHER STORY.
Get updates on press releases directly from NeutriSci International! Subscribe to our mailing list today and be the first to know when we publish updates and new press releases.
NeutriSci International complies with Canada’s Anti-Spam Legislation (CASL) and will not spam or sell your information to third party groups.
FOLLOW @NEUTRISCI ON TWITTER
- " @neutrisci PROVIDES UPDATE ON PATENT PENDING TECHNOLOGY" - Read our latest #pressrelease here:… https://t.co/qYuAMWzXnp 2 weeks ago
- " @neutrisci AND @NutritionalHigh ENTER INTO AGREEMENT TO DEVELOP, MANUFACTURE & DISTRIBUTE CANNABIS INFUSED PRODUCT… https://t.co/d9oJ9cE2PB 3 weeks ago
- "NEUTRISI ANNOUNCES PARTNERSHIP WITH ROGERS CUP PRESENTED BY NATIONAL BANK" - Read our latest #pressrelease here:… https://t.co/DuMVgXdEhb 2 months ago
- Stay tuned... https://t.co/hhFZImRPoa 2 months ago
NEUTRISCI IN THE NEWS
Lexaria Bioscience Enters Global Licensing Agreement with Neutrisci International
(NetworkNewsWire, Feb 26, 2018)
From Nutraceuticals to Cannabinoid Pharmaceuticals
(NetworkNewsWire, Jan 26, 2018)
Cannabis MOU Develops Better Drug Delivery System
(Stockhouse, Jan 09, 2018)
NeutriSci, Scientus Pharma in R&D Pact for Medical Cannabinoid
(BioTuesdays, Jan 08, 2018)
NeutriSci Enters Research and Development MOU with Scientus Pharma Inc
(NetworkNewsWire, Jan 08, 2018)
PRESS RELEASES
NEUTRISCI AND NUTRITIONAL HIGH ENTER INTO AGREEMENT TO DEVELOP, MANUFACTURE & DISTRIBUTE CANNABIS INFUSED PRODUCTS
Vancouver, British Columbia – May 30, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and [...]
NEUTRISCI ANNOUNCES PARTNERSHIP WITH ROGERS CUP PRESENTED BY NATIONAL BANK
Vancouver, British Columbia – April 19, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]
NEUTRISCI TO COMPLETE SHARE SETTLEMENT
Vancouver, British Columbia – March 27, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]
NEUTRISCI FILES PATENT APPLICATION
Vancouver, British Columbia – March 1, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]
NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT
Vancouver, British Columbia – February 26th, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) and Lexaria [...]